Lundvall A, Zetterström C
St Erik's Eye Hospital, Polhemsgatan 50, SE-112 82 Stockholm, Sweden.
Br J Ophthalmol. 2000 Jul;84(7):791-3. doi: 10.1136/bjo.84.7.791.
To evaluate the long term results of cataract surgery with intraocular lens implantation (IOL) in children with uveitis.
The study included 10 eyes in seven children (age 3.5-10 years, mean 6.5 years). The cataract surgery included capsulorhexis of the anterior and the posterior capsule, anterior vitrectomy in some eyes, and implantation of a heparin surface modified (HSM) poly(methyl methacrylate) (PMMA) IOL into the capsular bag.
Follow up periods ranged from 1 to 5 years. Best corrected visual acuity after surgery reached 20/50-20/20 in all but two eyes. Opacities or membranes requiring reoperation developed in seven eyes. Glaucoma developed in three eyes after the cataract operation.
These results suggest that implantation of a HSM PMMA IOL is an alternative to correct aphakia also in children with uveitis.
评估葡萄膜炎患儿白内障摘除联合人工晶状体植入术(IOL)的长期效果。
该研究纳入了7名儿童的10只眼(年龄3.5 - 10岁,平均6.5岁)。白内障手术包括前后囊连续环形撕囊,部分眼行前部玻璃体切除术,并将肝素表面改性(HSM)聚甲基丙烯酸甲酯(PMMA)人工晶状体植入囊袋内。
随访时间为1至5年。除2只眼外,其余所有眼术后最佳矫正视力均达到20/50 - 20/20。7只眼出现了需要再次手术的混浊或膜形成。3只眼在白内障手术后发生了青光眼。
这些结果表明,对于葡萄膜炎患儿,植入肝素表面改性的聚甲基丙烯酸甲酯人工晶状体也是矫正无晶状体眼的一种选择。